The announcement of Sonoma Pharmaceuticals' next-generation pulse lavage irrigation solution in the European Union is likely to have a positive impact on the company's stock price in the short term. The new product aims to improve surgical outcomes and reduce complications, which may lead to increased sales and market share for the company in the EU. This news is highly relevant and important for investors in SNOA, and the confidence in this analysis is relatively high.